Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
72 hedge funds and large institutions have $144M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 12 closing their positions.
76% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 17
13% more capital invested
Capital invested by funds: $127M → $144M (+$16.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 77 → 72 (-5)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Senzar Asset Management
New York
|
+$4.73M |
| 2 |
DA
DSC Advisors
Chicago,
Illinois
|
+$3.05M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.78M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.61M |
| 5 |
JP Morgan Chase
New York
|
+$1.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.72M |
| 2 |
AC
Ascend Capital
Orinda,
California
|
-$1.93M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$1.83M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.64M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.6M |
FOMX Hedge Fund Activity: Q4 2015 in Review
72 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q4 2015, worth a combined $144M — up 13% from $127M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of FOMX and 8 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 30 added.
The largest buyer was Senzar Asset Management, adding an estimated $4.73M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $3.72M sold.
- 72 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q4 2015, down from 77 in Q3 2015.
- Funds reported $144M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q4 2015, up 13% quarter-over-quarter.
- 8 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q4 2015 and 12 closed out, a net change of -4 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q4 2015 was Senzar Asset Management, an estimated $4.73M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q4 2015 was PFM Health Sciences, an estimated $3.72M sold.
Based on aggregated 13F filings for Q4 2015.